The selected newsroom has been added to your list of favorites. Go to My Favorites

Our News on Newswise

Newswise: 20241106_Brown_Foundation_Award_106.jpg

Brown Foundation Award for Excellence in Oncology Nursing honors Tiffany Richards

The University of Texas MD Anderson Cancer Center today honored Tiffany Richards, Ph.D., A.P.R.N., A.N.P.-B.C., A.O.C.N.P., with the 2024 Brown Foundation Award for Excellence in Oncology Nursing.
6-Nov-2024 5:50 PM EST Add to Favorites

Newswise: 6724fb81cf818_JenBickelHeadshot.jpg

Jennifer Bickel, M.D., Named MD Anderson Vice President and Chief Wellness Officer

The University of Texas MD Anderson Cancer Center today announced the selection of Jennifer Bickel, M.D., as the institution’s inaugural vice president and chief wellness officer (CWO). She will begin on January 6, 2025. Working closely with the...
1-Nov-2024 9:10 AM EDT Add to Favorites

Newswise: 67225c7bd3816_paulcinciripini.jpg.resize.jpg

Quitting Smoking After Cancer Diagnosis Improves Survival Across a Wide Variety of Cancers

Smokers who are diagnosed with cancer now have more incentive to quit, as researchers from The University of Texas MD Anderson Cancer Center have found survival outcomes were optimized when patients quit smoking within six months of their...
30-Oct-2024 2:00 PM EDT Add to Favorites

MD Anderson Research Highlights for October 30, 2024

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s...
30-Oct-2024 12:00 PM EDT Add to Favorites

Newswise: 6719b4c45e182_mariacabanillas.jpg.resize.810.1150.high.jpg

Combining Targeted Therapy and Immunotherapy Improves Overall Survival in Patients with Anaplastic Thyroid Cancer

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS) in patients with anaplastic thyroid carcinoma (ATC).
24-Oct-2024 11:00 AM EDT Add to Favorites

Newswise: 67191c9a2e6ba_JenniferFinkelHeadshot.jpg

MD Anderson Expands Arts Experience Program to Enhance Healing and Well-Being for Patients

As part of its ongoing commitment to patient comfort and healing, The University of Texas MD Anderson Cancer Center today announced a new focus on art to support the revitalization and expansion of its clinical facilities. This initiative will...
23-Oct-2024 2:00 PM EDT Add to Favorites

MD Anderson Research Highlights for October 16, 2024

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s...
16-Oct-2024 12:00 PM EDT Add to Favorites

Allison Institute Scientific Symposium Features Spatial Biology Breakthroughs, $5 Million Gift to Support Further Efforts

The James P. Allison Institute at The University of Texas MD Anderson Cancer Center hosted its second annual scientific symposium on Oct. 10. The symposium, with more than 900 attendees, featured two Nobel laureates and a $5 million gift from the...
14-Oct-2024 5:20 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: BenjaminSmith.jpg

Mastectomy Plus Reconstruction Has Highest Rate of Complication, Complication-Related Costs of Guideline-Concordant Therapies for Early Breast Cancer

In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
27-Sep-2016 3:05 PM EDT

Newswise: Liang_H_Bronto.jpg

Can Gender Play a Role in Determining Cancer Treatment Choices?

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

Newswise: ZhiminLu.jpg

MD Anderson Study Reveals New Insight Into Tumor Progression

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Newswise: Lee_M.jpg

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

Newswise: 204929_Chhatwal_Jjpg.jpg

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

See All Experts

Our YouTube Videos

About

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The institution’s sole mission is to end cancer for patients and their families around the world, and, in 1971, it became one of the nation’s first National Cancer Institute (NCI)-designated comprehensive cancer centers. MD Anderson is No. 1 for cancer in U.S. News & World Report’s “Best Hospitals” rankings and has been named one of the nation’s top two hospitals for cancer since the rankings began in 1990. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).

Experts

close
1.31752